» Articles » PMID: 7888224

A Broadly Neutralizing Human Monoclonal Antibody Against Gp41 of Human Immunodeficiency Virus Type 1

Overview
Publisher Mary Ann Liebert
Date 1994 Dec 1
PMID 7888224
Citations 168
Authors
Affiliations
Soon will be listed here.
Abstract

We have established a hybridoma clone, designated 2F5, secreting a neutralizing human monoclonal antibody (MAb) specific for gp41 of human immunodeficiency virus type 1 (HIV-1). The epitope of MAb 2F5 was mapped to amino acid sequence Glu-Leu-Asp-Lys-Trp-Ala on the ectodomain of gp41. In this study different in vitro test systems were used to characterize the neutralizing properties of MAb 2F5. In syncytium inhibition assays, fusion inhibition experiments, and neutralization assays on different HIV-susceptible cells (H9, U937, and peripheral blood mononuclear cells) MAb 2F5 showed broad-spectrum neutralizing capacity against HIV-1 laboratory isolates IIIB, MN, RF, and SF2. In addition, primary isolates from AIDS patients were also neutralized.

Citing Articles

Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies.

Bermejo-Jambrina M, van der Donk L, van Hamme J, Wilflingseder D, de Bree G, Prins M EMBO J. 2024; 43(7):1135-1163.

PMID: 38418557 PMC: 10987522. DOI: 10.1038/s44318-024-00061-0.


Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G.

Delviks-Frankenberry K, Ojha C, Hermann K, Hu W, Torbett B, Pathak V Mol Ther Nucleic Acids. 2023; 33:794-809.

PMID: 37662965 PMC: 10470399. DOI: 10.1016/j.omtn.2023.08.007.


Antimicrobial efficacy and inactivation kinetics of a novel LED-based UV-irradiation technology.

Schobel H, Diem G, Kiechl J, Chiste D, Bertacchi G, Mayr A J Hosp Infect. 2023; 135:11-17.

PMID: 36754288 PMC: 10041887. DOI: 10.1016/j.jhin.2022.12.023.


Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.

Lakhashe S, Amacker M, Hariraju D, Vyas H, Morrison K, Weiner J Front Immunol. 2022; 13:788619.

PMID: 35273592 PMC: 8902080. DOI: 10.3389/fimmu.2022.788619.


HIV-1 Infection via TNTs Is Impeded by Targeting C5aR.

Bertacchi G, Posch W, Wilflingseder D Biomolecules. 2022; 12(2).

PMID: 35204813 PMC: 8868603. DOI: 10.3390/biom12020313.